Micafungin Drug Interactions: What to Avoid and What to Tell Your Doctor

One of the advantages of micafungin over some other antifungals is its relatively limited drug interaction profile. Because micafungin is not primarily metabolized through the cytochrome P450 (CYP450) enzyme system — the main pathway responsible for interactions with hundreds of drugs — it avoids many of the interaction problems seen with azole antifungals like voriconazole or fluconazole. However, some interactions are clinically meaningful and require monitoring or dose adjustment. Here is what you need to know.

Why Micafungin Has Fewer Interactions Than Azole Antifungals

Azole antifungals (like fluconazole, voriconazole, and itraconazole) are potent inhibitors of CYP3A4, CYP2C9, and other CYP enzymes, which is the reason they interact with dozens of medications including statins, immunosuppressants, anticoagulants, and many others. Micafungin, by contrast, is a weak inhibitor of CYP3A4 and is metabolized primarily through non-CYP pathways (arylsulfatase, catechol O-methyltransferase, and hydroxylation). This results in far fewer significant drug interactions.

Clinically Important Interactions to Know About

Sirolimus (Rapamune) — Moderate Interaction

Micafungin increases sirolimus blood levels by approximately 21% (measured as area under the curve, or AUC). Sirolimus is an immunosuppressant used in organ transplant patients. Higher sirolimus levels can increase the risk of toxicity including kidney problems, high blood pressure, and increased infection risk. If you take sirolimus and are started on micafungin, your physician should monitor sirolimus blood levels and be prepared to reduce the sirolimus dose if toxicity develops.

Nifedipine (Procardia, Adalat) — Moderate Interaction

Micafungin increases nifedipine blood levels by approximately 18% (AUC) and increases peak concentration (Cmax) by approximately 42%. Nifedipine is a calcium channel blocker used for high blood pressure (hypertension) and chest pain (angina). Higher nifedipine levels can cause excessive blood pressure lowering, headache, facial flushing, and ankle swelling. Monitor blood pressure closely during concurrent use and reduce the nifedipine dose if needed.

Itraconazole (Sporanox) — Moderate Interaction

Micafungin increases itraconazole levels by approximately 22% (AUC) and by 11% (Cmax). Itraconazole is an oral antifungal used for certain infections. Elevated itraconazole levels can increase the risk of itraconazole toxicity including heart failure, liver problems, and drug interactions downstream. Patients receiving both drugs should be monitored for signs of itraconazole toxicity.

Saccharomyces boulardii (Probiotic) — Avoid Combination

Micafungin, like other systemic antifungal medications, can reduce the effectiveness of Saccharomyces boulardii-containing probiotics (brands such as Florastor). This is a logical interaction: since micafungin kills fungi, it will also affect the live fungi in these probiotic supplements. Avoid using S. boulardii probiotics during micafungin treatment.

Lonafarnib (Zokinvy) — Serious Interaction, Avoid

Micafungin may increase lonafarnib levels through weak CYP3A4 inhibition. Lonafarnib is a drug used for the rare aging disorder progeria (Hutchinson-Gilford Progeria Syndrome). Because lonafarnib has a narrow therapeutic window and is a sensitive CYP3A4 substrate, the combination should generally be avoided. If coadministration is unavoidable, reduce the lonafarnib dose and closely monitor for QT interval prolongation and other toxicity.

Medications That Do NOT Significantly Interact With Micafungin

One of the major clinical advantages of micafungin is that it does not significantly interact with many drugs commonly used in the immunocompromised patients who need it most:

Cyclosporine — No clinically significant pharmacokinetic interaction; micafungin does not alter cyclosporine levels

Tacrolimus — No significant interaction; levels do not change meaningfully

Mycophenolate mofetil (CellCept) — No significant pharmacokinetic interaction

Prednisolone — No clinically significant interaction

Fluconazole — Co-administration does not alter the pharmacokinetics of either drug

Voriconazole — No pharmacokinetic interaction

Ritonavir — No significant interaction; important for HIV patients

IV Drug Incompatibilities: Do Not Mix in the Same Line

Beyond pharmacokinetic drug interactions, micafungin also has physical compatibility issues with many IV medications. Micafungin should NEVER be mixed in the same IV bag or infused simultaneously through the same IV line as other medications, because it can precipitate (form visible particles) when mixed with many common drugs. Always flush the IV line thoroughly before and after micafungin administration and use a dedicated lumen when possible.

What to Tell Your Doctor Before Starting Micafungin

Before starting micafungin, give your physician a complete list of all medications, vitamins, supplements, and herbal products you take. Specifically mention:

All immunosuppressants (cyclosporine, tacrolimus, sirolimus, mycophenolate)

Blood pressure medications, especially nifedipine and other calcium channel blockers

Any other antifungal medications

Probiotic supplements containing Saccharomyces boulardii

Any rare disease medications or orphan drugs

For a full overview of side effects and safety monitoring, read our guide on micafungin side effects: what to expect and when to call your doctor.